Medical News

RSS

AlphaRx, Venturepharm sign supply agreement for ARX1088's API

AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.

17 Dec 2009

Federal tech panel still defining electronic health records terminology

The mid-December "milestone" for a federal advisory panel to come up with a definition of "meaningful use" of electronic medical records has come and gone, Modern Healthcare reports. That definition is to be used by the Centers for Medicare and Medicaid Services to determine who is eligible for a share of $34 billion in subsidies provided as part of the February stimulus bill. The members of the federal panel began shaping their definition in May.

17 Dec 2009

Lieberman's health care move still reverberating

Politico: "Sen. Joe Lieberman (I-Conn.) is taking a thrashing from his former Democratic colleagues and liberal activists for forcing a Medicare expansion out of the health bill. But in the end, Lieberman may have done President Barack Obama one of the biggest favors in the health care debate. That's because any bill with the Medicare buy-in would have drawn fierce opposition from doctors and hospitals, two groups Obama has worked hard to keep on board.

17 Dec 2009

House votes to extend COBRA benefits, delay Medicare physician pay cuts

The House of Representatives voted yesterday to delay Medicare doctor payment cuts and extend COBRA benefits.

17 Dec 2009

Pelosi signals openness to bill without public option, others also eye possibilities

House Speaker Nancy Pelosi signaled Wednesday that she is open to health care reform that doesn't include a public option, "a strong signal that Congress could agree on a plan early next year," McClatchy reports.

17 Dec 2009

Connectyx Technologies Holding Group, United States Medical Supply form distribution partnership

Connectyx Technologies Holding Group Inc. announced today that it has formed a distribution partnership with United States Medical Supply, a leading Mail Order distributor of Diabetic Supplies, Respiratory Supplies and Medications as well as Bladder Control Products and the VED Erectile Dysfunction System.

17 Dec 2009

Positive results from DURECT's Phase IIb POSIDUR clinical trial for post-surgical pain

DURECT Corporation announced today positive results from a 60 patient Phase IIb clinical trial of POSIDUR(TM), a proprietary product under development for the treatment of post-surgical pain.

17 Dec 2009

Sonomax Hearing Healthcare attains Phase IV milestone in its off-the-shelf, custom earpieces development

Sonomax Hearing Healthcare Inc. attains the Phase IV milestone and is only one milestone away from successfully completing the development of its off-the-shelf, self-fitting custom earpieces.

17 Dec 2009

Pelosi signals openness to bill without public option but progressives chafe

17 Dec 2009

Masimo PI promising for continuous and noninvasive monitoring of systemic blood flow in preterm infants

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that new research findings, published in the November 2009 issue of the Journal of Perinatology, show that Masimo perfusion index (PI) accurately predicts low superior vena cava flow (SVC) in preterm, very-low-birth-weight infants--representing a promising method for continuous and noninvasive monitoring of systemic blood flow.

17 Dec 2009

Alcon increases its financial support for NovaBay Pharmaceuticals' research and development efforts

NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company creating a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that effective immediately, its partner, Alcon Inc. has increased its on-going financial support of the company's research and development efforts by more than $2 million per year. The additional funding is expected to enhance NovaBay's pre-clinical and clinical development programs in the areas of eye, ear and sinus infections, as well as contact lens solutions.

17 Dec 2009

Arrayit Diagnostics to begin marketing its OvaDx Pre-Symptomatic Ovarian Cancer Blood Test in 2010

John Howell, CEO of Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today formally commented on the anticipated timeline for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development - the rights to which have been assigned exclusively to the Company by Arrayit Corporation.

17 Dec 2009

LUMEDX receives ACC-NCDR ACTION Registry-GWTG software vendor certification

The American College of Cardiology has certified LUMEDX, a leading provider of integrated cardiovascular imaging and information systems, as an ACC-NCDR ACTION Registry-GWTG software vendor. The new ACC-NCDR ACTION Registry-GWTG is a unified registry collecting data for patients with acute myocardial infarction. LUMEDX’s Export to ACTION Registry-GWTG solution collects data at the point of care and submits it electronically to the ACC-NCDR, streamlining registry participation.

17 Dec 2009

Therapure Biopharma to fill/finish nimotuzumab at its Canadian GMP certified fill suite

David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).

17 Dec 2009

Anadys Pharmaceuticals reports positive 4-week results from its ANA598 Phase II study for HCV

Anadys Pharmaceuticals, Inc. today announced preliminary results from a planned interim analysis of data at four weeks for the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.

17 Dec 2009

CDI purchases third FONAR UPRIGHT Multi-Position MRI

FONAR Corporation, The Inventor of MR Scanning, announced today that the Center for Diagnostic Imaging (CDI) (Minneapolis, MN) has purchased a third FONAR UPRIGHT® Multi-Position™ MRI. It is scheduled to be installed in CDI's OpenScan MRI center in Duluth, Minnesota, replacing the current low-field open-sided MRI scanner in that center.

17 Dec 2009

Avecia Biologics to be acquired by Merck

Merck & Co. Inc., (operating in the United Kingdom as MSD) and Avecia Investments Limited today announced that they have entered into a definitive agreement by which Merck will acquire the biologics business of the Avecia group through a Merck affiliate (Merck Sharp & Dohme (Holdings) Limited or "MSD"). Avecia Biologics is a contract manufacturing organization with specific expertise in microbial-derived biologics. Financial details of the transaction were not disclosed.

17 Dec 2009

BDSI's BEMA Buprenorphine Phase 2 study meets primary efficacy endpoint

BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint was achieved in the Company’s Phase 2 pain study assessing the efficacy and safety of BEMA Buprenorphine. The positive results follow BDSI’s March 2009 announcement of favorable Phase 1 study results.

17 Dec 2009

Second-quarter fiscal 2010 results announced by Schiff Nutrition International

Schiff Nutrition International, Inc., today announced results for the fiscal 2010 second quarter and six months ended November 30, 2009.

17 Dec 2009

Labopharm commences regulatory approval process in Europe for its twice-daily tramadol-acetaminophen

Labopharm Inc. today announced it has initiated the regulatory approval process for its twice-daily tramadol-acetaminophen formulation in Europe under the Decentralized Procedure (DCP). The DCP provides an efficient mechanism that allows a company to simultaneously pursue regulatory approval for a medicinal product in multiple jurisdictions in Europe.

17 Dec 2009

Medical News

AlphaRx, Venturepharm sign supply agreement for ARX1088's API

Federal tech panel still defining electronic health records terminology

Lieberman's health care move still reverberating

House votes to extend COBRA benefits, delay Medicare physician pay cuts

Pelosi signals openness to bill without public option, others also eye possibilities

Connectyx Technologies Holding Group, United States Medical Supply form distribution partnership

Positive results from DURECT's Phase IIb POSIDUR clinical trial for post-surgical pain

Sonomax Hearing Healthcare attains Phase IV milestone in its off-the-shelf, custom earpieces development

Pelosi signals openness to bill without public option but progressives chafe

Masimo PI promising for continuous and noninvasive monitoring of systemic blood flow in preterm infants

Alcon increases its financial support for NovaBay Pharmaceuticals' research and development efforts

Arrayit Diagnostics to begin marketing its OvaDx Pre-Symptomatic Ovarian Cancer Blood Test in 2010

LUMEDX receives ACC-NCDR ACTION Registry-GWTG software vendor certification

Therapure Biopharma to fill/finish nimotuzumab at its Canadian GMP certified fill suite

Anadys Pharmaceuticals reports positive 4-week results from its ANA598 Phase II study for HCV

CDI purchases third FONAR UPRIGHT Multi-Position MRI

Avecia Biologics to be acquired by Merck

BDSI's BEMA Buprenorphine Phase 2 study meets primary efficacy endpoint

Second-quarter fiscal 2010 results announced by Schiff Nutrition International

Labopharm commences regulatory approval process in Europe for its twice-daily tramadol-acetaminophen

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News